Salarius Pharmaceuticals Company Insiders

Salarius Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.5317) % which means that it has lost $0.5317 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1087) %, meaning that it created substantial loss on money invested by shareholders. Salarius Pharmaceuticals' management efficiency ratios could be used to measure how well Salarius Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.94 in 2025. Return On Capital Employed is likely to drop to -0.0029 in 2025. At this time, Salarius Pharmaceuticals' Other Current Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 14.2 M in 2025, whereas Total Assets are likely to drop slightly above 2.9 M in 2025. Common Stock Shares Outstanding is likely to rise to about 975.1 K in 2025, despite the fact that Net Loss is likely to grow to (27 M).

Salarius Pharmaceuticals Workforce Comparison

Salarius Pharmaceuticals Insider Trading

Salarius Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Salarius Pharmaceuticals often depends on how effective the management is. Salarius Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Salarius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Salarius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Salarius Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Salarius Pharmaceuticals. Check Salarius Pharmaceuticals' Beneish M Score to see the likelihood of Salarius Pharmaceuticals' management manipulating its earnings.

When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.